Pharmacy Benefit Management Market Size, Share & Trends Analysis Report By Business Model (Standalone PBM, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), By Region, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Business Model
  • 1.2.2. End-use
• 1.3. 1.3 Research Methodology
  • 1.3.1. Commodity flow analysis
  • 1.3.2. Information procurement
    • 1.3.2.1. Purchased database
    • 1.3.2.2. GVR'S internal database
    • 1.3.2.3. Primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Market Segmentation
• 2.3. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis

Chapter 4. Pharmacy Benefit Management Market: Business Model Estimates & Trend Analysis

• 4.1. Pharmacy Benefit Management Market: Business Model Segment Dashboard
• 4.2. Business Model Movement & Market Share Analysis, 2024 & 2033
• 4.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by Business Model
  • 4.3.1. Standalone PBM
    • 4.3.1.1. Standalone Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 4.3.2. Health Insurance Providers
    • 4.3.2.1. Health Insurance Providers Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 4.3.3. Retail Pharmacy
    • 4.3.3.1. Retail Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 5. Pharmacy Benefit Management Market: End-use Estimates & Trend Analysis

• 5.1. Pharmacy Benefit Management Market: End-use Segment Dashboard
• 5.2. End-use Movement & Market Share Analysis, 2024 & 2033
• 5.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by End-use
  • 5.3.1. Commercial
    • 5.3.1.1. Commercial Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
  • 5.3.2. Federal
    • 5.3.2.1. Federal Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 6. Pharmacy Benefit Management Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.6. Oceania
  • 6.6.1. Australia
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.2. New Zealand
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. New Zealand market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market position analysis, 2024
• 7.4. List of Companies
  • 7.4.1. CVS Health
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Cigna
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Optum, Inc.
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. MedImpact
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Anthem
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Change Healthcare
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Prime Therapeutics LLC
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. HUB International Limited
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Elixir Rx Solutions LLC
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Express Scripts Canada
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives

List of Tables

• Table 1 List of Abbreviations
• Table 2 Global pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 3 Global pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 4 Global pharmacy benefit management market, by region, 2021 - 2033 (USD Million)
• Table 5 North America pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 6 North America pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 7 North America pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
• Table 8 U.S. pharmacy benefit management market, by procedure, 2021 - 2033 (USD Million)
• Table 9 U.S. pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 10 U.S. pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
• Table 11 U.S. pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
• Table 12 Canada pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 13 Canada pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 14 Europe pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 15 Europe pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 16 Europe pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
• Table 17 UK pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 18 UK pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 19 Germany pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 20 Germany pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 21 France pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 22 France pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 23 Italy pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 24 Italy pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 25 Italy pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
• Table 26 Italy pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
• Table 27 Spain pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 28 Spain pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 29 Sweden pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 30 Sweden pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 31 Norway pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 32 Norway pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 33 Denmark pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 34 Denmark pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 35 Asia Pacific pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 36 Asia Pacific pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 37 Asia Pacific pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
• Table 38 Asia Pacific pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
• Table 39 Asia Pacific pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
• Table 40 Australia pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 41 Australia pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 42 New Zealand pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 43 New Zealand pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 44 Rest of world pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
• Table 45 Rest of world pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
• Table 46 Rest of world pharmacy benefit management market, by country, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Pharmacy benefit management: market outlook
• Fig. 9 Pharmacy benefit management competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Pharmacy benefit management market driver impact
• Fig. 15 Pharmacy benefit management market restraint impact
• Fig. 16 Pharmacy benefit management market strategic initiatives analysis
• Fig. 17 Pharmacy benefit management market: Business model movement analysis
• Fig. 18 Pharmacy benefit management market: Business model outlook and key takeaways
• Fig. 19 Standalone PBM market estimates and forecasts, 2021 - 2033
• Fig. 20 Health insurance providers market estimates and forecasts, 2021 - 2033
• Fig. 21 Retail pharmacy market estimates and forecasts, 2021 - 2033
• Fig. 22 Pharmacy benefit management market: End-use movement analysis
• Fig. 23 Pharmacy benefit management market: End-use outlook and key takeaways
• Fig. 24 Commerical pharmacy benefit managementing market estimates and forecasts, 2021 - 2033
• Fig. 25 Federal pharmacy benefit managementing market estimates and forecasts, 2021 - 2033
• Fig. 26 Global pharmacy benefit management market: Regional movement analysis
• Fig. 27 Global pharmacy benefit management market: Regional outlook and key takeaways
• Fig. 28 North America market estimates and forecasts, 2021 - 2033
• Fig. 29 U.S. market estimates and forecasts, 2021 - 2033
• Fig. 30 Canada market estimates and forecasts, 2021 - 2033
• Fig. 31 Europe market estimates and forecasts, 2021 - 2033
• Fig. 32 UK market estimates and forecasts, 2021 - 2033
• Fig. 33 Germany market estimates and forecasts, 2021 - 2033
• Fig. 34 France market estimates and forecasts, 2021 - 2033
• Fig. 35 Italy market estimates and forecasts, 2021 - 2033
• Fig. 36 Spain market estimates and forecasts, 2021 - 2033
• Fig. 37 Sweden market estimates and forecasts, 2021 - 2033
• Fig. 38 Norway market estimates and forecasts, 2021 - 2033
• Fig. 39 Denmark market estimates and forecasts, 2021 - 2033
• Fig. 40 Oceania market estimates and forecasts, 2021 - 2033
• Fig. 41 Australia market estimates and forecasts, 2021 - 2033
• Fig. 42 New Zealand market estimates and forecasts, 2021 - 2033
• Fig. 43 Rest of world market estimates and forecasts, 2021 - 2033
• Fig. 44 Strategy framework